Recommendations for whole genome sequencing in diagnostics for rare diseases.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
09 2022
Historique:
received: 23 12 2021
accepted: 21 04 2022
pubmed: 17 5 2022
medline: 9 9 2022
entrez: 16 5 2022
Statut: ppublish

Résumé

In 2016, guidelines for diagnostic Next Generation Sequencing (NGS) have been published by EuroGentest in order to assist laboratories in the implementation and accreditation of NGS in a diagnostic setting. These guidelines mainly focused on Whole Exome Sequencing (WES) and targeted (gene panels) sequencing detecting small germline variants (Single Nucleotide Variants (SNVs) and insertions/deletions (indels)). Since then, Whole Genome Sequencing (WGS) has been increasingly introduced in the diagnosis of rare diseases as WGS allows the simultaneous detection of SNVs, Structural Variants (SVs) and other types of variants such as repeat expansions. The use of WGS in diagnostics warrants the re-evaluation and update of previously published guidelines. This work was jointly initiated by EuroGentest and the Horizon2020 project Solve-RD. Statements from the 2016 guidelines have been reviewed in the context of WGS and updated where necessary. The aim of these recommendations is primarily to list the points to consider for clinical (laboratory) geneticists, bioinformaticians, and (non-)geneticists, to provide technical advice, aid clinical decision-making and the reporting of the results.

Identifiants

pubmed: 35577938
doi: 10.1038/s41431-022-01113-x
pii: 10.1038/s41431-022-01113-x
pmc: PMC9437083
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1017-1021

Subventions

Organisme : Medical Research Council
ID : MR/V037307/1
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Genome Res. 2017 Nov;27(11):1895-1903
pubmed: 28887402
Eur J Hum Genet. 2016 Nov;24(11):1584-1590
pubmed: 27165007
Nature. 2014 Jul 17;511(7509):344-7
pubmed: 24896178
Eur J Hum Genet. 2022 Sep;30(9):1011-1016
pubmed: 35361922
Am J Hum Genet. 2019 Oct 3;105(4):719-733
pubmed: 31564432
Hum Mutat. 2013 Oct;34(10):1313-21
pubmed: 23776008
Nature. 2020 Jul;583(7814):96-102
pubmed: 32581362
Eur J Hum Genet. 2014 Feb;22(2):160-70
pubmed: 23942201
Eur J Hum Genet. 2016 Jan;24(1):2-5
pubmed: 26508566
Genome Biol. 2019 Dec 19;20(1):291
pubmed: 31856913
Genet Med. 2020 Jul;22(7):1254-1261
pubmed: 32313153

Auteurs

Erika Souche (E)

Center for Human Genetics, KU Leuven, Gasthuisberg, Laboratory for Molecular Diagnosis, Leuven, Belgium.

Sergi Beltran (S)

CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona (UB), Barcelona, Spain.

Erwin Brosens (E)

Erasmus MC University Medical Center - Sophia Children's Hospital, Department of Clinical Genetics, Rotterdam, The Netherlands.

John W Belmont (JW)

Illumina, Inc., Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

Magdalena Fossum (M)

Dept of Pediatric Surgery, Rigshospitalet, Faculty of Health and Medical Sciences, Copenhagen University, Denmark, Dept. of Women's and Children's health, Karolinska Institute, Stockholm, Sweden.

Olaf Riess (O)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Christian Gilissen (C)

Department of Human Genetics and Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands.

Amin Ardeshirdavani (A)

Agilent Technologies, Diagnostics and Genomics Group, Leuven, Belgium.

Gunnar Houge (G)

Department of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.

Marielle van Gijn (M)

Department of Genetics, University Medical Center Groningen, University Groningen, Groningen, The Netherlands.

Jill Clayton-Smith (J)

Manchester Centre For Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, M13 9WL, UK.
Division of Evolution and Genomic Sciences School of Biological Sciences University of Manchester, Manchester, UK.

Matthis Synofzik (M)

Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.

Nicole de Leeuw (N)

Department of Human Genetics, and Donders Centre for Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.

Zandra C Deans (ZC)

Genomics Quality Assessment, NHS Lothian, Edinburgh, Scotland.

Yasemin Dincer (Y)

Lehrstuhl für Sozialpädiatrie, Technische Universität München, Munich, Germany.
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ), Martinsried, Germany.

Sebastian H Eck (SH)

MVZ Martinsried GmbH, Martinsried, Germany.

Saskia van der Crabben (S)

Amsterdam University Medical Centers, location AMC, Department of Clinical Genetics, Amsterdam, The Netherlands.

Meena Balasubramanian (M)

Highly Specialised Osteogenesis Imperfecta Service and Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK.

Holm Graessner (H)

University Hospital Tübingen, Institute for Medical Genetics and Applied Genomics and Centre for Rare Diseases, Calwerstr. 7, 72076, Tübingen, Germany.

Marc Sturm (M)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Helen Firth (H)

Dept of Clinical Genetics, Box 134, Cambridge University Hospitals, Cambridge, UK.

Alessandra Ferlini (A)

Unit of Medical Genetics, University Hospital & Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Rima Nabbout (R)

Pediatric Neurology. reference centre for rare epilepsies. Hôpital Necker Enfants malades, APHP, Université de Paris, Institut Imagine (INSERM UMR 1163), Paris, France.

Elfride De Baere (E)

Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Thomas Liehr (T)

Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Jena, Germany.

Milan Macek (M)

Department of biology and medical genetics, 2nd Faculty of Medicine Charles University and University hospital Motol, Prague, Czechia.

Gert Matthijs (G)

Center for Human Genetics, KU Leuven, Gasthuisberg, Laboratory for Molecular Diagnosis, Leuven, Belgium.

Hans Scheffer (H)

Radboud university medical center, Department of Human Genetics, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Peter Bauer (P)

CENTOGENE GmbH, Am Strande 7, 18055, Rostock, Germany.

Helger G Yntema (HG)

Radboud university medical center, Department of Human Genetics, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Marjan M Weiss (MM)

Radboud university medical center, Department of Human Genetics, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. Janneke.Weiss@radboudumc.nl.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH